Clinical Trial Update: Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a different antiplatelet therapy strategy after coronary artery bypass graft surgery has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Bypass Grafting
• Coronary Artery Disease

Snippet

Sponsor: Ruijin Hospital | Conditions: Coronary Artery Bypass, Antiplatelet Agents | Phase 4 | Status: COMPLETED | Results posted: 2019-07-01